Increased Mammalian Target of Rapamycin Signaling Contributes to the Accumulation of Protein Oxidative Damage in a Mouse Model of Down's Syndrome.

Increased Mammalian Target of Rapamycin Signaling Contributes to the Accumulation of Protein Oxidative Damage in a Mouse Model of Down's Syndrome.

Item
http://www.wikidata.org/entity/Q38816807
mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders.Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies.HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.Oxidant production and SOD1 protein expression in single skeletal myofibers from Down syndrome mice.mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia.Exosomal biomarkers in Down syndrome and Alzheimer's disease.Early and Selective Activation and Subsequent Alterations to the Unfolded Protein Response in Down Syndrome Mouse Models.Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
P2860

Increased Mammalian Target of Rapamycin Signaling Contributes to the Accumulation of Protein Oxidative Damage in a Mouse Model of Down's Syndrome.

Item
http://www.wikidata.org/entity/Q38816807
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Increased Mammalian Target of ...... ouse Model of Down's Syndrome.
@en
type
label
Increased Mammalian Target of ...... ouse Model of Down's Syndrome.
@en
prefLabel
Increased Mammalian Target of ...... ouse Model of Down's Syndrome.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Increased Mammalian Target of ...... ouse Model of Down's Syndrome.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698